{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-025568","form_type":"8-K","ticker":"COCP","cik":"0001412486","company_name":"Cocrystal Pharma, Inc.","filed_at":"2025-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.345826+00:00","generated_at":"2026-05-16T15:52:05.277503+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cocrystal Pharma to present at NobleCon 21 on Dec 3, 2025","bullets":["CFO/co-CEO James Martin to give Company overview and clinical progress update.","Presentation at Noble Capital Markets' 21st Emerging Growth Equity Conference on Dec 3, 2025 at 10:00 AM ET.","Conference held at Florida Atlantic University in Boca Raton, Florida.","Webcast will be archived for 90 days on Cocrystal's website starting Dec 4."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-025568","json":"https://secwatch.observer/filing/0001493152-25-025568.json","markdown":"https://secwatch.observer/filing/0001493152-25-025568.md","text":"https://secwatch.observer/filing/0001493152-25-025568.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412486/000149315225025568/0001493152-25-025568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412486/000149315225025568/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:52:05.277503+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}